Paper24255575
Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment.
Zhang Y and 5 others. Chin J Cancer Res, 2013. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment. Papers, record 24255575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24255575
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22286106 | Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. | Cell Signal | 2012 | https://conductscience.org/library/papers/22286106 | PubMed |
| 2 | 19525723 | Friend or foe? Resolving the impact of glial responses in glaucoma. | J Glaucoma | 2009 | https://conductscience.org/library/papers/19525723 | PubMed |
| 3 | 21480238 | Tumor microenvironment and progression. | J Surg Oncol | 2011 | https://conductscience.org/library/papers/21480238 | PubMed |
| 4 | 22510398 | Primary brain tumours in adults. | Lancet | 2012 | https://conductscience.org/library/papers/22510398 | PubMed |
| 5 | 22341931 | Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy. | Clin Neurol Neurosurg | 2012 | https://conductscience.org/library/papers/22341931 | PubMed |
| 6 | 22440877 | Management of multifocal and multicentric gliomas. | Neurosurg Clin N Am | 2012 | https://conductscience.org/library/papers/22440877 | PubMed |
| 7 | 22420577 | Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics. | Clin Pharmacokinet | 2012 | https://conductscience.org/library/papers/22420577 | PubMed |
| 8 | 22417747 | Antioxidant and bioenergetic coupling between neurons and astrocytes. | Biochem J | 2012 | https://conductscience.org/library/papers/22417747 | PubMed |
| 9 | 22537212 | Free radicals and antioxidants: updating a personal view. | Nutr Rev | 2012 | https://conductscience.org/library/papers/22537212 | PubMed |
| 10 | 22549953 | Links between metabolism and cancer. | Genes Dev | 2012 | https://conductscience.org/library/papers/22549953 | PubMed |
| 11 | 22440863 | Current surgical management of insular gliomas. | Neurosurg Clin N Am | 2012 | https://conductscience.org/library/papers/22440863 | PubMed |
| 12 | 22499675 | Glial hemichannels and their involvement in aging and neurodegenerative diseases. | Rev Neurosci | 2012 | https://conductscience.org/library/papers/22499675 | PubMed |
| 13 | 21036578 | The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. | Phytomedicine | 2011 | https://conductscience.org/library/papers/21036578 | PubMed |
| 14 | 22440866 | Characteristics and treatment of seizures in patients with high-grade glioma: a review. | Neurosurg Clin N Am | 2012 | https://conductscience.org/library/papers/22440866 | PubMed |
| 15 | 20925470 | Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. | Expert Rev Neurother | 2010 | https://conductscience.org/library/papers/20925470 | PubMed |
| 16 | 22192883 | Targeting the S and G2 checkpoint to treat cancer. | Drug Discov Today | 2012 | https://conductscience.org/library/papers/22192883 | PubMed |
| 17 | 20378318 | Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. | Phytomedicine | 2010 | https://conductscience.org/library/papers/20378318 | PubMed |
| 18 | 22190972 | Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment. | Clin Dev Immunol | 2011 | https://conductscience.org/library/papers/22190972 | PubMed |
| 19 | 22493542 | Mouse models of pancreatic cancer. | World J Gastroenterol | 2012 | https://conductscience.org/library/papers/22493542 | PubMed |
| 20 | 22549954 | Astrocytes and disease: a neurodevelopmental perspective. | Genes Dev | 2012 | https://conductscience.org/library/papers/22549954 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42925475 | Characterization of Anticancer Activities of Rhodiola rosea L. Extracts in Breast Tumor Cells: Phenotype Changes and Potential Mechanisms of Action. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/42925475 | PubMed |
| 42889017 | Salidroside inhibits glioma cell migration and proliferation through CYP2E1-neuroglobin-cytochrome c mediated redox axis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42889017 | PubMed |
| 42720006 | Mechanistic Investigation of Salidroside Modulates Iron Overload to Mitigate Radiation-Induced Heart Disease. | Cardiovasc Ther | 2026 | https://conductscience.org/library/papers/42720006 | PubMed |
| 42018209 | Salidroside in heavy metal toxicity: a mechanistic review of antioxidant, anti-inflammatory, and anti-apoptotic pathways. | Biometals | 2026 | https://conductscience.org/library/papers/42018209 | PubMed |
| 41003973 | Salidroside and inflammation-linked disorders: integrative insights into the pharmacological effects and mechanistic targets. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/41003973 | PubMed |
| 40343296 | Salidroside impedes Ang II-infused myocardial fibrosis by activating the SIRT1-Nrf2 pathway. | Iran J Basic Med Sci | 2025 | https://conductscience.org/library/papers/40343296 | PubMed |
| 39636431 | Salidroside overcomes cisplatin resistance in ovarian cancer via the inhibition of CRNDE-mediated autophagy. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/39636431 | PubMed |
| 38333759 | Salidroside alleviates LPS-induced liver injury and inflammation through SIRT1- NF-κB pathway and NLRP3 inflammasome. | Iran J Basic Med Sci | 2024 | https://conductscience.org/library/papers/38333759 | PubMed |
| 37920527 | Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway. | Heliyon | 2023 | https://conductscience.org/library/papers/37920527 | PubMed |
| 37423604 | Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624-mediated PD-L1 pathway. | Thorac Cancer | 2023 | https://conductscience.org/library/papers/37423604 | PubMed |
| 37375742 | Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37375742 | PubMed |
| 35695011 | Rhodiola rosea polysaccharides promote the proliferation of bone marrow haematopoietic progenitor cells and stromal cells in mice with aplastic anaemia. | Pharm Biol | 2022 | https://conductscience.org/library/papers/35695011 | PubMed |
| 34377008 | The Promoting Effect of Traumatic Brain Injury on the Incidence and Progression of Glioma: A Review of Clinical and Experimental Research. | J Inflamm Res | 2021 | https://conductscience.org/library/papers/34377008 | PubMed |
| 32587256 | Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32587256 | PubMed |
| 32560471 | Protective Evaluation of Compounds Extracted from Root of Rhodiola rosea L. against Methylglyoxal-Induced Toxicity in a Neuronal Cell Line. | Molecules | 2020 | https://conductscience.org/library/papers/32560471 | PubMed |
| 32144560 | Advances in Research on Anticancer Properties of Salidroside. | Chin J Integr Med | 2021 | https://conductscience.org/library/papers/32144560 | PubMed |
| 31637020 | The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports. | Signal Transduct Target Ther | 2019 | https://conductscience.org/library/papers/31637020 | PubMed |
| 31452742 | Cryptotanshinone inhibits lung cancer invasion via microRNA-133a/matrix metalloproteinase 14 regulation. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31452742 | PubMed |
| 30393593 | Rhodiola rosea L.: an herb with anti-stress, anti-aging, and immunostimulating properties for cancer chemoprevention. | Curr Pharmacol Rep | 2017 | https://conductscience.org/library/papers/30393593 | PubMed |
| 29774132 | Natural products: a hope for glioblastoma patients. | Oncotarget | 2018 | https://conductscience.org/library/papers/29774132 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24255575
GET https://conductscience.org/api/papers/v1/24255575/references?page=2